result of vitimelin tablet and vitimelin oil in vitiligo
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2021/04/033014
- Lead Sponsor
- DrVasishths Ayuremedies
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
1-Children of either gender aged group between 10 - 16 years.
2- Children having classical sign and symptom and diagnosed as vitiligo / Shwitra.
3- Patient should be capable of obeying the instruction related to course of therapy.
1- Children below 10 years and above 16 years of age.
2- Patches more than 30% of the body, Broad continuous irregular patches.
3- Children with albinism will be excluded.
4- White anesthetic spot which are characterized of leprosy.
5- Patches in genital area and only lip area are excluded from the study.
6- Patient not fulfilling the inclusion criteria.
7- Patient suffering from any other known systemic and chronic disease / Autoimmune
disorder.
8- Patient not willing to give consent for participation in the Research study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in VASI score.Timepoint: 3 month
- Secondary Outcome Measures
Name Time Method To evaluate the safety of trial drug (Vitimelin Tablet and Vitimelin Oil).Timepoint: 3 months